Morales-Primo A, Becker I, Pedraza-Zamora C, Zamora-Chimal J
Immune Netw. 2024; 24(2):e14.
PMID: 38725676
PMC: 11076297.
DOI: 10.4110/in.2024.24.e14.
Beyzay F, Zavaran Hosseini A, Hazrati A, Karimi M, Soudi S
Bioimpacts. 2023; 13(5):393-403.
PMID: 37736336
PMC: 10509742.
DOI: 10.34172/bi.2023.25282.
Mehravaran A, Rezaei Nasab M, Mirahmadi H, Sharifi I, Alijani E, Nikpoor A
Iran J Basic Med Sci. 2019; 22(8):922-931.
PMID: 31579449
PMC: 6760488.
DOI: 10.22038/ijbms.2019.35739.8515.
Antonia A, Gibbs K, Trahair E, Pittman K, Martin A, Schott B
Front Cell Infect Microbiol. 2019; 9:280.
PMID: 31440475
PMC: 6693555.
DOI: 10.3389/fcimb.2019.00280.
Novais F, Wong A, Villareal D, Beiting D, Scott P
J Immunol. 2018; 200(5):1737-1745.
PMID: 29367210
PMC: 6178231.
DOI: 10.4049/jimmunol.1701597.
Memory T cells in cutaneous leishmaniasis.
Glennie N, Scott P
Cell Immunol. 2016; 309:50-54.
PMID: 27493096
PMC: 5127769.
DOI: 10.1016/j.cellimm.2016.07.010.
Regulation of immunity during visceral Leishmania infection.
Rodrigues V, Cordeiro-da-Silva A, Laforge M, Silvestre R, Estaquier J
Parasit Vectors. 2016; 9:118.
PMID: 26932389
PMC: 4774109.
DOI: 10.1186/s13071-016-1412-x.
CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.
Novais F, Scott P
Semin Immunopathol. 2015; 37(3):251-9.
PMID: 25800274
PMC: 4439344.
DOI: 10.1007/s00281-015-0475-7.
CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity.
Okwor I, Jia P, Mou Z, Onyilagha C, Uzonna J
PLoS Negl Trop Dis. 2014; 8(11):e3300.
PMID: 25412267
PMC: 4238992.
DOI: 10.1371/journal.pntd.0003300.
The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis.
Da Silva Santos C, Brodskyn C
Front Public Health. 2014; 2:165.
PMID: 25325049
PMC: 4178373.
DOI: 10.3389/fpubh.2014.00165.
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
Seyed N, Taheri T, Vauchy C, Dosset M, Godet Y, Eslamifar A
PLoS One. 2014; 9(10):e108848.
PMID: 25310094
PMC: 4195657.
DOI: 10.1371/journal.pone.0108848.
Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis.
Dantas M, de Oliveira J, Carvalho L, Passos S, Queiroz A, Guimaraes L
Mem Inst Oswaldo Cruz. 2014; 109(2):202-9.
PMID: 24676653
PMC: 4015249.
DOI: 10.1590/0074-0276130312.
Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis.
Gois L, Mehta S, Rodrigues M, Schooley R, Badaro R, Grassi M
Mem Inst Oswaldo Cruz. 2013; 109(1):9-14.
PMID: 24141962
PMC: 3975712.
DOI: 10.1590/0074-0276130174.
Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model.
GolAli E, Jaafari M, Khamesipour A, Abbasi A, Saberi Z, Badiee A
Iran J Basic Med Sci. 2013; 15(5):1032-45.
PMID: 23493437
PMC: 3586918.
Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice.
Peters N, Bertholet S, Lawyer P, Charmoy M, Romano A, Ribeiro-Gomes F
J Immunol. 2012; 189(10):4832-41.
PMID: 23045616
PMC: 3596879.
DOI: 10.4049/jimmunol.1201676.
Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance.
Kautz-Neu K, Schwonberg K, Fischer M, Schermann A, von Stebut E
Med Microbiol Immunol. 2012; 201(4):581-92.
PMID: 22983754
DOI: 10.1007/s00430-012-0261-2.
CD8(+) T cells in leishmania infections: friends or foes?.
Stager S, Rafati S
Front Immunol. 2012; 3:5.
PMID: 22566891
PMC: 3342007.
DOI: 10.3389/fimmu.2012.00005.
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.
Seyed N, Zahedifard F, Safaiyan S, Gholami E, Doustdari F, Azadmanesh K
PLoS Negl Trop Dis. 2011; 5(9):e1295.
PMID: 21909442
PMC: 3167772.
DOI: 10.1371/journal.pntd.0001295.
Regulation of CD8+ T cell responses to infection with parasitic protozoa.
Jordan K, Hunter C
Exp Parasitol. 2010; 126(3):318-25.
PMID: 20493842
PMC: 2934887.
DOI: 10.1016/j.exppara.2010.05.008.
Optimized subunit vaccine protects against experimental leishmaniasis.
Bertholet S, Goto Y, Carter L, Bhatia A, Howard R, Carter D
Vaccine. 2009; 27(50):7036-45.
PMID: 19786136
PMC: 2783536.
DOI: 10.1016/j.vaccine.2009.09.066.